EUVIMEDOdkrijte EUVIMED
LeserbriefOpen access · CC BY-NC-ND 4.0

A five‐gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia

Maria Rosaria Sapienza iD, Sabina Chiaretti, Deborah Cardinali, Saveria Mazzara, Roberto Chiarle, Robin Foà, Stefano A Pileri

Hematological Oncology · 2023

DOI: 10.1002/hon.3136 ↗

At a glance

Leserbrief in Hematological Oncology, 2023. Written by Maria Rosaria Sapienza and 6 co-authors. Institution: Division of Hematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy. Major MEDLINE topics: Central Nervous System Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Cited 4 times so far (Crossref); 11 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Associazione Italiana Ricerca sul Cancro, Special 5x1000 Program Metastases, Milano.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

The outcome of patients with acute lymphoblastic leukemia (ALL) has progressively improved over the years thanks to a more precise diagnostic and prognostic work ‐ up at presentation based on biological and molecular features, to the increasing use of targeted therapies and to a more personalized follow ‐ up and management of patients. 1,2 Nonetheless, refractory/relapsed cases have an aggressive clinical course and a poor prognosis. At a time when the prognostic likelihood of adult ALL is improving, an extramedullary dissemination to the central nervous system (CNS) is becoming an increasing unmet clinical need. 1 CNS localization represents a primary cause of treatment failure and mortality among adult ALL patients. 1 A sizable proportion of ALL patients develop a CNS dissemination: in about 3%–5% of patients it can be detected already at diagnosis while in 30%–40% of patients it develops during the course of the disease. 1 Irrespective of the initial CNS status, all therapeutic schemes include CNS prophylaxis, mostly based on the combined use of systemic and intrathecal chemotherapy. 1 The molecular mechanisms underlying a dissemination to the CNS are still poorly understood and molecular markers predicting CNS involvement in patients with adult ALL are currently lacking. These markers would be critical to implement a tailored therapy that could guide a more effective treatment in patients at a higher risk of CNS localization, in order to prevent a CNS relapse, and to limit the degree of CNS prophylaxis in patients with a low risk of CNS involvement.

Subjects

MeSH terms (MEDLINE)

Central Nervous System NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHumansAdultCentral Nervous System

Author keywords

ALLCNSNanoStringdisseminationgene expressionleukemiatherapy

Authors and institutions

  • Division of Hematopathology, IEO European Institute of Oncology IRCCS, Milan, Italy.
  • Hematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
  • Department of Pathology, Boston Children's Hospital, Boston, MA, USA.
  • Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.

ORCID profiles: Maria Rosaria Sapienza

Funding

  • Associazione Italiana Ricerca sul Cancro
  • Special 5x1000 Program Metastases
  • Milano

Cite

APA

Sapienza, M. R., Chiaretti, S., Cardinali, D., Mazzara, S., Chiarle, R., Foà, R., & Pileri, S. A. (2023). A five‐gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia. Hematological Oncology. https://doi.org/10.1002/hon.3136

Vancouver

Sapienza MR, Chiaretti S, Cardinali D, Mazzara S, Chiarle R, Foà R, et al. A five‐gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia. Hematological Oncology. 2023. doi:10.1002/hon.3136

BibTeX
@article{Sapienza2023,
  author = {Sapienza, Maria Rosaria and Chiaretti, Sabina and Cardinali, Deborah and Mazzara, Saveria and Chiarle, Roberto and Foà, Robin and Pileri, Stefano A},
  title = {A five‐gene signature may associate with central nervous system dissemination in adult acute lymphoblastic leukemia},
  journal = {Hematological Oncology},
  year = {2023},
  doi = {10.1002/hon.3136}
}
Start for free →